Results 101 to 110 of about 13,031,587 (294)

Circular RNA expression landscapes in myelodysplastic neoplasms: Associations with mutational signatures and disease progression

open access: yesMolecular Oncology, EarlyView.
In this explorative study, the abundance of circular RNA molecules in bone marrow stem cells was found to be elevated in patients with high‐risk myelodysplastic neoplasms, and to be associated with an increased risk of progression to acute myeloid leukemia.
Eileen Wedge   +17 more
wiley   +1 more source

Transnational Literature, November 2014: Articles

open access: yes, 2014
All articles from Transnational Literature, November 2014, in one file for ease of printing and ...

core  

IMPDH inhibition enhances cytarabine efficacy in SAMHD1‐expressing leukaemia cells via guanine nucleotide depletion

open access: yesMolecular Oncology, EarlyView.
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla   +9 more
wiley   +1 more source

The division of labour between the Basque articles in the indefinite domain

open access: yesFontes Linguae Vasconum
The usage of the Basque definite and indefinite articles differs significantly from their Romance counterparts. While the definite article is used as a default article for NPs without another determiner, the exact function of the indefinite article in ...
Silvie Strauss
doaj   +1 more source

Collaborative articles in percent of all published articles by years.

open access: yes, 2014
Collaborative articles in percent of all published articles by years.
Jil Carl (698050)   +4 more
core   +1 more source

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

open access: yesMolecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan   +16 more
wiley   +1 more source

Use of citation analysis to predict the outcome of the 2001 Research Assessment Exercise for Unit of Assessment (UoA) 61: Library and Information Management

open access: yesInformation Research: An International Electronic Journal, 2001
A citation study was carried out to predict the outcome of the 2001 Research Assessment Exercise. The correlation between scores achieved by academic departments in the UK in the 1996 Research Assessment Exercise, and the number of citations received by ...
Alison Holmes, Charles Oppenheim
doaj  

Sources of the articles (% of articles, N = 27).

open access: yes, 2013
Sources of the articles (% of articles, N = 27).
Qi Sun (127)   +5 more
core   +1 more source

Transcriptional profiling of circulating extracellular vesicles from prebiopsy prostate cancer patients

open access: yesMolecular Oncology, EarlyView.
RNA profiling of circulating extracellular vesicles (EVs) from blood samples of men undergoing prostate biopsy identifies transcripts associated with clinically significant prostate cancer. Integrative analysis with public tumor datasets links EV‐derived gene signatures to tumor stage and progression‐free survival, highlighting CASP3, XRCC2, and RIT1 ...
Stefan Werner   +14 more
wiley   +1 more source

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

open access: yesMolecular Oncology, EarlyView.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary   +1 more
wiley   +1 more source

Home - About - Disclaimer - Privacy